Biodesix Inc
NASDAQ:BDSX
Biodesix Inc
Revenue
Biodesix Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biodesix Inc
NASDAQ:BDSX
|
Revenue
$49.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$360.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$206B
|
CAGR 3-Years
8%
|
CAGR 5-Years
22%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Biodesix Inc
Revenue Breakdown
Breakdown by Geography
Biodesix Inc
Breakdown by Segments
Biodesix Inc
Total Revenue:
49.1m
USD
|
Diagnostic Tests:
45.2m
USD
|
See Also
What is Biodesix Inc's Revenue?
Revenue
49.1m
USD
Based on the financial report for Dec 31, 2023, Biodesix Inc's Revenue amounts to 49.1m USD.
What is Biodesix Inc's Revenue growth rate?
Revenue CAGR 5Y
19%
Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Biodesix Inc have been 3% over the past three years , 19% over the past five years .